LG Chem: Diabetes Mellitus, Type 2 trials

The registry lists 18 Diabetes Mellitus, Type 2 studies with LG Chem as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 4Phase 3 9Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus PatientsCompletedNCT06495281
• A Study of LC542019 in Healthy Subjects and Subjects With T2DMCompletedNCT06333977Phase 1
• Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes MellitusStatus unknownNCT05281029
• A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin AloneStatus unknownNCT04255238Phase 3
• BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.Status unknownNCT03867942Phase 1
• An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)CompletedNCT03864432Phase 1
• A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)CompletedNCT03842267Phase 3
• Gemigliptin, Dapagliflozin, Empagliflozin DDI StudyStatus unknownNCT03565458Phase 1
• Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)CompletedNCT03202563Phase 4
• Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)CompletedNCT02831361Phase 3
• An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With GemigliptinCompletedNCT02290301
• Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)CompletedNCT02126358Phase 3
• Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 DiabetesStatus unknownNCT02089126Phase 3
• A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)CompletedNCT01968044Phase 3
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4
• Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dCompletedNCT01787396Phase 3
• Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DiabetesCompletedNCT01602003Phase 3
• Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 DiabetesCompletedNCT01601990Phase 3